Approval · Notice of Compliance 5105 · 1995
COZAAR: Notice of Compliance 5105
Issued September 28, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5105
- Date
- September 28, 1995
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Angiotensin II receptor antagonist
Products in this notice
Medicinal ingredients
- LOSARTAN POTASSIUM 25 MG per TAB
- LOSARTAN POTASSIUM 50 MG per TAB
- LOSARTAN POTASSIUM 100 MG per TAB